Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
91 participants
OBSERVATIONAL
2009-06-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
NCT03539562
Role of Maternal Physical Exercise on Spontaneous Labor Onset
NCT02460185
Non-pharmacological Resources in Assisting Labor
NCT01389128
Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women
NCT00664118
Labor Analgesia in the Latent Phrase
NCT00647725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Nulliparous
* Singleton pregnancy
* Low risk pregnancy
Exclusion Criteria
* Women who request cesarean delivery
* Women who are pregnant with twins
* Women who plan induction
* Women who deliver before 37 weeks
* Women enrolled in the "Centering Pregnancy" program at the Family Birth Center
* High risk pregnancies
* Severe mental illness that impairs cognition or function
* Suicidal ideation
* Women who do not speak English or Spanish
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beth Darnall, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beth Darnall, PhD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5K12HD04348807
Identifier Type: -
Identifier Source: secondary_id
5203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.